These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19541129)

  • 1. [Clinical trials in child neuromuscular disease].
    Halbert C; Chabrol B
    Arch Pediatr; 2009 Jun; 16(6):684-6. PubMed ID: 19541129
    [No Abstract]   [Full Text] [Related]  

  • 2. Provision and financing of assistive technology devices in Germany: a bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy.
    Henschke C
    Health Policy; 2012 May; 105(2-3):176-84. PubMed ID: 22349416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Untreatable" neuromuscular disease. Treatment trials and symptomatic treatment of amyotrophic lateral sclerosis.
    Festoff BW; Perurena OH; Singer PA
    J Kans Med Soc; 1983 Jun; 84(6):312-7. PubMed ID: 6348186
    [No Abstract]   [Full Text] [Related]  

  • 4. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors.
    J Neurol Sci; 1995 May; 129 Suppl():1-10. PubMed ID: 7595596
    [No Abstract]   [Full Text] [Related]  

  • 5. Should patients with neuromuscular disease be denied the choice of the treatment of mechanical ventilation?
    Rumbak MJ; Walker RM
    Chest; 2001 Mar; 119(3):683-4. PubMed ID: 11243942
    [No Abstract]   [Full Text] [Related]  

  • 6. In defense of myoblast transplantation research in preteens with Duchenne muscular dystrophy.
    Post SG
    Pediatr Transplant; 2010 Nov; 14(7):809-12. PubMed ID: 19732377
    [No Abstract]   [Full Text] [Related]  

  • 7. The design of clinical trials in amyotrophic lateral sclerosis.
    Azulay JP
    Adv Neurol; 1995; 68():225-7. PubMed ID: 8787233
    [No Abstract]   [Full Text] [Related]  

  • 8. Airway clearance in Duchenne muscular dystrophy.
    Kravitz RM
    Pediatrics; 2009 May; 123 Suppl 4():S231-5. PubMed ID: 19420150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal ventilation in progressive neuromuscular disease: experience in adults and adolescents.
    Simonds AK
    Monaldi Arch Chest Dis; 2000 Jun; 55(3):237-41. PubMed ID: 10948673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental therapy in Duchenne muscular dystrophy].
    van den Bergen JC; Straathof CS; Aartsma-Rus A; Ginjaar IB; Verschuuren JJ
    Ned Tijdschr Geneeskd; 2009 May; 153(18):870-5. PubMed ID: 19475867
    [No Abstract]   [Full Text] [Related]  

  • 11. A 2009 perspective on the 2004 American Thoracic Society statement, "respiratory care of the patient with Duchenne muscular dystrophy".
    Finder JD
    Pediatrics; 2009 May; 123 Suppl 4():S239-41. PubMed ID: 19420152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands.
    Muntoni F; Bushby K; van Ommen G
    Neuromuscul Disord; 2005 Jun; 15(6):450-7. PubMed ID: 15907292
    [No Abstract]   [Full Text] [Related]  

  • 13. The risks of therapeutic misconception and individual patient (n=1) "trials" in rare diseases such as Duchenne dystrophy.
    Aartsma-Rus A
    Neuromuscul Disord; 2011 Jan; 21(1):13-5. PubMed ID: 21051233
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis: theories and therapies.
    Rowland LP
    Ann Neurol; 1994 Feb; 35(2):129-30. PubMed ID: 8109893
    [No Abstract]   [Full Text] [Related]  

  • 17. The American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation.
    Birnkrant DJ
    Pediatrics; 2009 May; 123 Suppl 4():S242-4. PubMed ID: 19420153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon in the treatment of amyotrophic lateral sclerosis].
    Akimov GA; Golovkin VI; Ankhimova ES; Maiorova LP; Reshetniak AV
    Sov Med; 1986; (12):51-5. PubMed ID: 3551109
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: What is next in ALS clinical trials?
    Hoke A
    Neurology; 2008 Apr; 70(16):1366; author reply 1366-7. PubMed ID: 18413595
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the therapy of amyotrophic lateral sclerosis: focus on excitotoxicity.
    Brighina L; Sala G; Ceresa C; Tremolizzo L; Ferrarese C
    Funct Neurol; 2001; 16(4 Suppl):189-202. PubMed ID: 11996516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.